Gilead Sciences Receives Canadian Approval For HIV Drug By: TalkMarkets February 20, 2017 at 15:03 PM EST Gilead Sciences Inc. announced that it has received approval in Canada for its Odefsey for treating HIV-1 infection. Read More >> Related Stocks: Gilead Sciences Gsk Plc ADR